Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Gatzemeier

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1991
Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone)G Groth, U Gatzemeier, K Häussingen, et al.
Seminars in Oncology|December 1, 1995
Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trialU Gatzemeier, M Heckmayer, R Neuhauss, et al.
Onkologie|June 1, 1990
Pirarubicin in advanced non-small cell lung cancer. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer SocietyP Drings, I U Günther, U Gatzemeier, et al.
Pneumologie (Stuttgart, Germany)|February 1, 1990
[Chemotherapy of small cell bronchial cancer with a combination of carboplatin, vincristine and etoposide]U Gatzemeier, W Achterrath, M Heckmayr, et al.
Onkologie|June 1, 1990
Chemotherapy with tauromustine in advanced non-small cell lung cancer. A trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer SocietyU Gatzemeier, P Drings, L Edler, et al.
Oncology|January 1, 1992
Carboplatin/etoposide/vincristine therapy in small cell lung cancerU Gatzemeier, J von Pawel, R Laumen, et al.
Seminars in Oncology|April 1, 1991
Phase III trial with and without lonidamine in non-small cell lung cancerU Gatzemeier, F Cavalli, K Häussinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2011
A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancerM Reck, R Kaiser, C Eschbach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancerU Gatzemeier, G Groth, C Butts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Gemcitabine plus etoposide in chemonaive extensive disease small-cell lung cancer: a multi-centre phase II studyJ Vansteenkiste, U Gatzemeier, C Manegold, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1991
Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone)G Groth, U Gatzemeier, K Häussingen, et al.
Seminars in Oncology|December 1, 1995
Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trialU Gatzemeier, M Heckmayer, R Neuhauss, et al.
Onkologie|June 1, 1990
Pirarubicin in advanced non-small cell lung cancer. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer SocietyP Drings, I U Günther, U Gatzemeier, et al.
Pneumologie (Stuttgart, Germany)|February 1, 1990
[Chemotherapy of small cell bronchial cancer with a combination of carboplatin, vincristine and etoposide]U Gatzemeier, W Achterrath, M Heckmayr, et al.
Onkologie|June 1, 1990
Chemotherapy with tauromustine in advanced non-small cell lung cancer. A trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer SocietyU Gatzemeier, P Drings, L Edler, et al.
Oncology|January 1, 1992
Carboplatin/etoposide/vincristine therapy in small cell lung cancerU Gatzemeier, J von Pawel, R Laumen, et al.
Seminars in Oncology|April 1, 1991
Phase III trial with and without lonidamine in non-small cell lung cancerU Gatzemeier, F Cavalli, K Häussinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2011
A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancerM Reck, R Kaiser, C Eschbach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancerU Gatzemeier, G Groth, C Butts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Gemcitabine plus etoposide in chemonaive extensive disease small-cell lung cancer: a multi-centre phase II studyJ Vansteenkiste, U Gatzemeier, C Manegold, et al.
Pageof 8